Pulmonary hypertension in two patients treated with bevacizumab for recurrent ovarian cancer

Gynecol Oncol. 2009 Nov;115(2):308-9. doi: 10.1016/j.ygyno.2009.08.003. Epub 2009 Sep 8.

Authors

Margaret Liotta¹, Peter G Rose, Pedro F Escobar

Affiliation

¹ The Cleveland Clinic, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, 9500 Euclid Ave, A-81, Cleveland, OH 441195, USA.

PMID: 19740533
DOI: 10.1016/j.ygyno.2009.08.003

No abstract available

Publication types

Case Reports

MeSH terms

Angiogenesis Inhibitors / adverse effects*
Angiogenesis Inhibitors / therapeutic use
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized
Bevacizumab
Female
Humans
Hypertension, Pulmonary / chemically induced*
Middle Aged
Neovascularization, Pathologic / drug therapy
Ovarian Neoplasms / blood supply
Ovarian Neoplasms / drug therapy*

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab